Overall, the results indicate that the combination of sodium butyrate with an anti-mouse PD-1 antibody effectively retards tumor growth and enhances the antitumor response by promoting and optimizing the tumor microenvironment. The gene discussed is PDCD1; the disease is neoplasm.